Ceribell

Ceribell P/B

The P/B (Price-to-Book Ratio) of Ceribell (CBLL) as of Nov 5, 2026 is 4.50. In the previous year, P/B (Price-to-Book Ratio) was 3.66 — a change of 23.07% (higher).

P/B

4.50

YoY

23.07%

Last updated:

P/B (Price-to-Book Ratio) of Ceribell is 2025 4.50 . P/B (Price-to-Book Ratio) of Ceribell was 2024 3.66 . It decreases by 23.07% higher compared to the previous year.

The Ceribell P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2022
-8.09 USD
Jan 1, 2023
-6.23 USD
Jan 1, 2024
3.66 USD
Jan 1, 2025
4.50 USD
The Ceribell P/B history
YEARP/BYoY
4.50+23.07%
3.66-158.72%
-6.23-23.03%
-8.09—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ceribell Stock analysis

What does Ceribell do? Ceribell, Inc. generates revenue through its Ceribell System, a point-of-care EEG platform designed for acute care settings. The system combines portable hardware with AI-powered algorithms, including the Clarity AI algorithm that provides real-time EEG interpretation, bedside alerts, and continuous monitoring for status epilepticus. Hospitals and healthcare providers purchase the Ceribell System to improve neurological diagnosis and management, particularly for patients with acute conditions requiring rapid seizure detection. The Ceribell EEG Portal is also offered as part of the solution to facilitate data access and management. The company's primary customers are healthcare institutions seeking to enhance patient care efficiency through advanced neurological monitoring. By enabling early detection and continuous monitoring, the Ceribell System supports precise treatment decisions and reduces hospital resource strain. The Clarity AI algorithm is a key differentiator, delivering real-time insights that address critical unmet needs in acute neurological care. Ceribell, Inc. focuses on transforming diagnosis and management of serious neurological conditions through its proprietary technology. The Ceribell System's portability and rapid deployment make it suitable for acute care environments where timely intervention is crucial. Healthcare providers use the system to monitor patients with suspected seizures, leveraging the AI-driven insights for immediate clinical action. Ceribell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ceribell stock

P/B (Price-to-Book Ratio) of Ceribell is 4.50 in 2025.

P/B (Price-to-Book Ratio) of Ceribell changed from 3.66 to 4.50, representing a 23.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Ceribell since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Ceribell with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ceribell

All Key Metrics — Ceribell